Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children AG Ziegler, M Rewers, O Simell, T Simell, J Lempainen, A Steck, ... Jama 309 (23), 2473-2479, 2013 | 1418 | 2013 |
Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans T Vatanen, AD Kostic, E d’Hennezel, H Siljander, EA Franzosa, ... Cell 165 (4), 842-853, 2016 | 1399 | 2016 |
Prevalence of celiac disease among children in Finland M Mäki, K Mustalahti, J Kokkonen, P Kulmala, M Haapalahti, T Karttunen, ... New England Journal of Medicine 348 (25), 2517-2524, 2003 | 1380 | 2003 |
The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes AD Kostic, D Gevers, H Siljander, T Vatanen, T Hyötyläinen, ... Cell host & microbe 17 (2), 260-273, 2015 | 1287 | 2015 |
Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability M Yassour, T Vatanen, H Siljander, AM Hämäläinen, T Härkönen, ... Science translational medicine 8 (343), 343ra81-343ra81, 2016 | 1032 | 2016 |
Toward defining the autoimmune microbiome for type 1 diabetes A Giongo, KA Gano, DB Crabb, N Mukherjee, LL Novelo, G Casella, ... The ISME journal 5 (1), 82-91, 2011 | 996 | 2011 |
Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes CT Brown, AG Davis-Richardson, A Giongo, KA Gano, DB Crabb, ... PloS one 6 (10), e25792, 2011 | 922 | 2011 |
A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus J Karjalainen, JM Martin, M Knip, J Ilonen, BH Robinson, E Savilahti, ... New England journal of medicine 327 (5), 302-307, 1992 | 778 | 1992 |
Environmental triggers and determinants of type 1 diabetes M Knip, R Veijola, SM Virtanen, H Hyoty, O Vaarala, HK Akerblom Diabetes 54 (suppl_2), S125-S136, 2005 | 749 | 2005 |
Fecal microbiota composition differs between children with β-cell autoimmunity and those without MC De Goffau, K Luopajärvi, M Knip, J Ilonen, T Ruohtula, T Härkönen, ... Diabetes 62 (4), 1238-1244, 2013 | 700 | 2013 |
A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM H Hyöty, M Hiltunen, M Knip, M Laakkonen, P Vähäsalo, J Karjalainen, ... Diabetes 44 (6), 652-657, 1995 | 598 | 1995 |
Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5‐year‐old children M Erkkola, M Kaila, BI Nwaru, C Kronberg‐Kippilä, S Ahonen, ... Clinical & Experimental Allergy 39 (6), 875-882, 2009 | 575 | 2009 |
Obesity and endocrine disorders in women taking valproate for epilepsy JIT Isojärvi, TJ Laatikainen, M Knip, AJ Pakarinen, KTS Juntunen, ... Annals of Neurology: Official Journal of the American Neurological …, 1996 | 559 | 1996 |
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes M Oresic, S Simell, M Sysi-Aho, K Nanto-Salonen, T Seppanen-Laakso, ... The Journal of experimental medicine 205 (13), 2975-2984, 2008 | 523 | 2008 |
Environmental factors in the etiology of type 1 diabetes HK Åkerblom, O Vaarala, H Hyöty, J Ilonen, M Knip American journal of medical genetics 115 (1), 18-29, 2002 | 515 | 2002 |
Safety of high-dose nicotinamide: a review M Knip, IF Douek, WPT Moore, HA Gillmor, AEM McLean, PJ Bingley, ... Diabetologia 43, 1337-1345, 2000 | 500 | 2000 |
Valproate, lamotrigine, and insulin‐mediated risks in women with epilepsy JIT Isojärvi, J Rättyä, VV Myllylä, M Knip, R Koivunen, AJ Pakarinen, ... Annals of neurology 43 (4), 446-451, 1998 | 478 | 1998 |
The role of the intestinal microbiota in type 1 diabetes mellitus M Knip, H Siljander Nature Reviews Endocrinology 12 (3), 154-167, 2016 | 472 | 2016 |
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens MJ Mina, T Kula, Y Leng, M Li, RD De Vries, M Knip, H Siljander, ... Science 366 (6465), 599-606, 2019 | 464 | 2019 |
Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial K Näntö-Salonen, A Kupila, S Simell, H Siljander, T Salonsaari, ... The Lancet 372 (9651), 1746-1755, 2008 | 448 | 2008 |